Loading insider details...
Latest Form 4 (Nov 6, 2026): Purchase of 5,000,000 ANVS shares, $5.00M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 6, 2026 | Annovis Bio, Inc. (ANVS) | Purchase | 5,000,000 | $5.00M |
| May 29, 2026 | Translational Development Acquisition Corp. (TDAC) | Purchase | 53,395 | $42.3K |
| May 22, 2026 | Annovis Bio, Inc. (ANVS) | Purchase | 2,562 | $4.5K |
| Apr 3, 2026 | Annovis Bio, Inc. (ANVS) | Purchase | 713,800 | $1.50M |
| Dec 9, 2025 | Annovis Bio, Inc. (ANVS) | Purchase | 30,000 | $130.2K |
| Nov 25, 2025 | Annovis Bio, Inc. (ANVS) | Purchase | 1,489 | $6.1K |
| Nov 22, 2025 | Annovis Bio, Inc. (ANVS) | Purchase | 10,000 | $34.9K |
| Nov 18, 2025 | Annovis Bio, Inc. (ANVS) | Purchase | 15,000 | $31.6K |
| Nov 12, 2025 | Annovis Bio, Inc. (ANVS) | Purchase | 975,610 | $2.00M |
| Sep 3, 2025 | Annovis Bio, Inc. (ANVS) | Grant/Award | 5,000 | $11.4K |